AMGN

Amgen Inc. · Healthcare · Drug Manufacturers - General
$432.42
-4.57 (-1.05%)
Mkt Cap: 233.38B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.6%
Dividend YieldN/A
Market Cap233.38B
Volume1.73M
Recent News
Blue Edge Capital LLC Purchases New Position in Amgen Inc. $AMGN
defenseworld.net · 2026-08-28
AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study
zacks.com · 2026-08-27
Arini Capital Management Ltd Buys Shares of 20,000 Amgen Inc. $AMGN
defenseworld.net · 2026-08-27
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
prnewswire.com · 2026-08-27
Amgen Touches 52-Week High: Buy, Sell or Hold the Stock?
zacks.com · 2026-08-24
Is AMGN Overvalued? DCF Says Worth $296
gurufocus.com · 2026-08-24

Unlock the Full Deep Scan

9 AI agents analyze AMGN across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →